Peptide record

TPDB10725

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
26 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10725
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP pep-lab Peptipedia Antifungipept CAFPdb dbAMP 3.0 i2APP
standard
No
A 26-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KWKLFKKIGIGAVLKVLTTGLPALIS
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C136H232N32O30
RNDCEQHMY
LK
2795.53
11.12
5
0
14
+5
-0.88
0.842
150.00
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
5500
1.97
3
Residue Composition
number
2
A
0
R
0
N
0
D
0
C
0
E
0
Q
3
G
0
H
3
I
5
L
5
K
0
M
1
F
1
P
1
S
2
T
1
W
0
Y
2
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 3 H: 0 I: 3 L: 5 K: 5 M: 0 F: 1 P: 1 S: 1 T: 2 W: 1 Y: 0 V: 2
Chemical Descriptors
26 reviewed residue count
C136H232N32O30 sequence-only estimate (linear, free termini)
2795.53 sequence-only estimate (linear, free termini)
11.12 sequence-only estimate (linear, free termini)
+5 sequence-only estimate (linear, free termini)
-0.88 sequence-only estimate (linear, free termini)
0.842 sequence-only estimate (linear, free termini)
Evidence Records 22 records
Evidence 1 Activity

Activity

MIC
Antibacterial
2-16 µg/mL

Target

Pseudomonas aeruginosa PAO1 and mutants or H103 or K799

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against P. aeruginosa PAO1 and mutants or H103 or K799 (MIC 2-16 ug/ml), E. coli UB1005 or Bort or O111:B4 (MIC 1-6 ug/ml), and S. typhimurium 14028sor MS7953s (
Evidence 2 Activity

Activity

MIC
Antibacterial
2-4 µg/mL

Target

S. typhimurium 14028sor MS7953s

Source & Reference

dbAMP DRAMP

Other

or H103 or K799 (MIC 2-16 ug/ml), E. coli UB1005 or Bort or O111:B4 (MIC 1-6 ug/ml), and S. typhimurium 14028sor MS7953s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia AT
Evidence 3 Activity

Activity

MIC
Antibacterial
4 µg/mL

Target

Enterobacter cloacae 218S

Source & Reference

dbAMP DRAMP

Other

or Bort or O111:B4 (MIC 1-6 ug/ml), and S. typhimurium 14028sor MS7953s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calc
Evidence 4 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Klebsiella pneumoniae ATCC 13883

Source & Reference

dbAMP DRAMP

Other

/ml), and S. typhimurium 14028sor MS7953s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calcoaceticus 8193 (MIC 2 ug/ml). Also, S. a
Evidence 5 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

X. maltophilia ATCC 13637

Source & Reference

dbAMP DRAMP

Other

s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calcoaceticus 8193 (MIC 2 ug/ml). Also, S. aureus (LC 1 uM), S. pyogenes (LC 2 uM). i
Evidence 6 Activity

Activity

MIC
Antibacterial
2 µg/mL

Target

A. calcoaceticus 8193

Source & Reference

dbAMP DRAMP

Other

ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calcoaceticus 8193 (MIC 2 ug/ml). Also, S. aureus (LC 1 uM), S. pyogenes (LC 2 uM). including resistance strains A. bauman
Evidence 7 Activity

Activity

MIC
Antibacterial
2-8 µg/mL

Target

A. baumannii

Source & Reference

dbAMP DRAMP

Other

2 ug/ml). Also, S. aureus (LC 1 uM), S. pyogenes (LC 2 uM). including resistance strains A. baumannii (MIC 2-8 ug/ml) ( Rodríguez-Hernández et al., 2006 ). Binds LPS:anti-inflammatory by reducing TNF-alpha r
Evidence 8 Activity

Activity

MIC
Antifungal
2-16 µg/mL

Target

Pseudomonas aeruginosa PAO1 and mutants or H103 or K799

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active against P. aeruginosa PAO1 and mutants or H103 or K799 (MIC 2-16 ug/ml), E. coli UB1005 or Bort or O111:B4 (MIC 1-6 ug/ml), and S. typhimurium 14028sor MS7953s (
Evidence 9 Activity

Activity

MIC
Antifungal
2-4 µg/mL

Target

S. typhimurium 14028sor MS7953s

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

or H103 or K799 (MIC 2-16 ug/ml), E. coli UB1005 or Bort or O111:B4 (MIC 1-6 ug/ml), and S. typhimurium 14028sor MS7953s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia AT
Evidence 10 Activity

Activity

MIC
Antifungal
4 µg/mL

Target

Enterobacter cloacae 218S

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

or Bort or O111:B4 (MIC 1-6 ug/ml), and S. typhimurium 14028sor MS7953s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calc
Evidence 11 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

Klebsiella pneumoniae ATCC 13883

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

/ml), and S. typhimurium 14028sor MS7953s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calcoaceticus 8193 (MIC 2 ug/ml). Also, S. a
Evidence 12 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

X. maltophilia ATCC 13637

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calcoaceticus 8193 (MIC 2 ug/ml). Also, S. aureus (LC 1 uM), S. pyogenes (LC 2 uM). i
Evidence 13 Activity

Activity

MIC
Antifungal
2 µg/mL

Target

A. calcoaceticus 8193

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calcoaceticus 8193 (MIC 2 ug/ml). Also, S. aureus (LC 1 uM), S. pyogenes (LC 2 uM). including resistance strains A. bauman
Evidence 14 Activity

Activity

MIC
Antifungal
2-8 µg/mL

Target

A. baumannii

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

2 ug/ml). Also, S. aureus (LC 1 uM), S. pyogenes (LC 2 uM). including resistance strains A. baumannii (MIC 2-8 ug/ml) ( Rodríguez-Hernández et al., 2006 ). Binds LPS:anti-inflammatory by reducing TNF-alpha r
Evidence 15 Activity

Activity

MIC
Antiparasitic
2-16 µg/mL

Target

Pseudomonas aeruginosa PAO1 and mutants or H103 or K799

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
active against P. aeruginosa PAO1 and mutants or H103 or K799 (MIC 2-16 ug/ml), E. coli UB1005 or Bort or O111:B4 (MIC 1-6 ug/ml), and S. typhimurium 14028sor MS7953s (
Evidence 16 Activity

Activity

MIC
Antiparasitic
2-4 µg/mL

Target

S. typhimurium 14028sor MS7953s

Source & Reference

dbAMP 3.0 DRAMP

Other

or H103 or K799 (MIC 2-16 ug/ml), E. coli UB1005 or Bort or O111:B4 (MIC 1-6 ug/ml), and S. typhimurium 14028sor MS7953s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia AT
Evidence 17 Activity

Activity

MIC
Antiparasitic
4 µg/mL

Target

Enterobacter cloacae 218S

Source & Reference

dbAMP 3.0 DRAMP

Other

or Bort or O111:B4 (MIC 1-6 ug/ml), and S. typhimurium 14028sor MS7953s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calc
Evidence 18 Activity

Activity

MIC
Antiparasitic
8 µg/mL

Target

Klebsiella pneumoniae ATCC 13883

Source & Reference

dbAMP 3.0 DRAMP

Other

/ml), and S. typhimurium 14028sor MS7953s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calcoaceticus 8193 (MIC 2 ug/ml). Also, S. a
Evidence 19 Activity

Activity

MIC
Antiparasitic
8 µg/mL

Target

X. maltophilia ATCC 13637

Source & Reference

dbAMP 3.0 DRAMP

Other

s (MIC 2-4 ug/ml). E. cloacae 218S (MIC 4 ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calcoaceticus 8193 (MIC 2 ug/ml). Also, S. aureus (LC 1 uM), S. pyogenes (LC 2 uM). i
Evidence 20 Activity

Activity

MIC
Antiparasitic
2 µg/mL

Target

A. calcoaceticus 8193

Source & Reference

dbAMP 3.0 DRAMP

Other

ug/ml), K. pneumoniae ATCC 13883 (MIC 8 ug/ml), X. maltophilia ATCC 13637 (MIC 8 ug/ml), A. calcoaceticus 8193 (MIC 2 ug/ml). Also, S. aureus (LC 1 uM), S. pyogenes (LC 2 uM). including resistance strains A. bauman
Evidence 21 Activity

Activity

MIC
Antiparasitic
2-8 µg/mL

Target

A. baumannii

Source & Reference

dbAMP 3.0 DRAMP

Other

2 ug/ml). Also, S. aureus (LC 1 uM), S. pyogenes (LC 2 uM). including resistance strains A. baumannii (MIC 2-8 ug/ml) ( Rodríguez-Hernández et al., 2006 ). Binds LPS:anti-inflammatory by reducing TNF-alpha r
Evidence 22 Activity

Activity

100% Hemolysis
Toxicity
>600 µM
Hemolytic Cytotoxic
100% Hemolysis | >600 | µM | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide. | Biochem J | 1998